Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-002303

EVP, CFO sold 1,070 shares at an average $6.63 ($7,093)

From the SEC's structured data for this filing

Trades in this filing

Hyllengren Eric J · EVP, CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-16 Sale : show line 1 in the form −1,041 $6.63 $6,901 24,785 D
2024-08-16 Sale : show line 2 in the form −29 $6.63 $192 24,756 D
Open-market sales · 1,070 sh · avg $6.63 · $7,093
Loading xslF345X05/form4.xml…